Skip to main content
. 2020 Aug 24;13:269–274. doi: 10.2147/JAA.S258561

Table 1.

Subject Characteristics and Baseline Biomarker Concentration in Plasma

Healthy Controls,
n=18
Asthmatics,
n=22
p-value
Age, years 25 (22–35) 26 (24–33) 0.76
Sex (male/female), n 9/9 12/10 0.78a
Atopy, n 4 12 0.04a
FEV1, l 4.0 (3.3–4.7) 3.8 (2.9–4.5) 0.67
FEV1, %p 101.3 (94.3–111.8) 95.2 (87.5–109.4) 0.25
Positive exercise test, n 1 9 0.013b
Fall in FEV1 during test, % 4.6 (0.0–6.8) 6.1 (3.0–18.8) 0.067
ICS, n 0 15 <0.001b
FeNO, ppb 15.8 (9.5–35.1) 21.8 (15.1–37.3) 0.31
Biomarkers in plasma
 IL-13, pg/mL 491 (413–104814) 767 (352–12472) 0.81
 TARC, pg/mL 75 (52–248) 70 (19–98) 0.26
 Periostin, pg/mL 495 (361–748) 522 (329–857) 0.76
 Cys-LT, pg/mL 559 (509–660) 646 (521–815) 0.23

Notes: Data are presented as median (IQR) or number. Atopy was defined as having a positive skin prick-test of airborne allergens. Positive exercise test was defined as having ≥10% fall in FEV1 after the exercise challenge test. p-value= statistical difference between healthy controls and asthmatics using Mann–Whitney U-test, Chi2-testa or Fisher’s Exact testb.

Abbreviations: FEV1, forced expiratory volume in 1 s; ICS, inhaled corticosteroids; FeNO, fractional exhaled NO at flow 50 mL/s.